Obesity Paradox in Ischemic Stroke: Clinical and Molecular Insights

Abstract

It has recently emerged the concept of “obesity paradox,” a term used to describe the unexpected improved prognosis and lower mortality rates found in several diseases in patients with higher body weight. Concerning stroke, few clinical studies have assessed this obesity paradox showing contradictory results. Therefore, our aim was to compare clinical evolution and inflammatory balance of obese and non-obese patients after ischemic stroke. We designed a prospective case-control study in patients with acute ischemic stroke categorized into obese (body mass index, BMI\u2009≥\u200930\xa0kg/m2) and non-obese (BMI\u2009<\u200930\xa0kg/m2). We compared clinical, anthropometric, radiological, and laboratory variables. The main outcome variable was the functional outcome at 3\xa0months. We included 98 patients (48 non-obese and 50 obese). No differences in functional outcome at 3\xa0months were found (p\u2009=\u20090.882) although a tendency of a greater recovery on neurological impairments was seen in obese subjects. Importantly, obese patients (p\u2009=\u20090.007) and patients who experienced poor outcome (p\u2009=\u20090.006) exhibited a higher reduction in body weight at 3\xa0months after stroke. Moreover, pro-inflammatory IL-6 levels (p\u2009=\u20090.002) were higher in the obese group. However, IL-6 levels decreased over the first week in obese while increased in non-obese. On the contrary, levels of the anti-inflammatory IL-10 rose over the first week in obese patients, whereas remained stable in non-obese. In summary, despite exhibiting several factors associated with poor outcome, obese patients do not evolve worse than non-obese after ischemic stroke. Obesity may counterbalance the inflammatory reaction through an anti-inflammatory stream enhanced in the first moments of stroke.